Immune cell boost may help islet transplants work better in type 1 diabetes
NCT ID NCT05973734
First seen Jun 16, 2026 · Last updated Jun 16, 2026
Summary
This early-phase study tests whether adding special immune cells to a standard islet transplant can help people with brittle type 1 diabetes better control their blood sugar. Participants will receive either their own regulatory T cells or donor bone marrow cells along with the transplant. The goal is to see if this approach is safe and feasible, and whether it reduces the need for insulin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Palo Alto, California, 94305, United States
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.